コンテンツへスキップ
Merck
  • Balancing the rates of new bone formation and polymer degradation enhances healing of weight-bearing allograft/polyurethane composites in rabbit femoral defects.

Balancing the rates of new bone formation and polymer degradation enhances healing of weight-bearing allograft/polyurethane composites in rabbit femoral defects.

Tissue engineering. Part A (2013-08-15)
Jerald E Dumas, Edna M Prieto, Katarzyna J Zienkiewicz, Teja Guda, Joseph C Wenke, Jesse Bible, Ginger E Holt, Scott A Guelcher
要旨

There is a compelling clinical need for bone grafts with initial bone-like mechanical properties that actively remodel for repair of weight-bearing bone defects, such as fractures of the tibial plateau and vertebrae. However, there is a paucity of studies investigating remodeling of weight-bearing bone grafts in preclinical models, and consequently there is limited understanding of the mechanisms by which these grafts remodel in vivo. In this study, we investigated the effects of the rates of new bone formation, matrix resorption, and polymer degradation on healing of settable weight-bearing polyurethane/allograft composites in a rabbit femoral condyle defect model. The grafts induced progressive healing in vivo, as evidenced by an increase in new bone formation, as well as a decrease in residual allograft and polymer from 6 to 12 weeks. However, the mismatch between the rates of autocatalytic polymer degradation and zero-order (independent of time) new bone formation resulted in incomplete healing in the interior of the composite. Augmentation of the grafts with recombinant human bone morphogenetic protein-2 not only increased the rate of new bone formation, but also altered the degradation mechanism of the polymer to approximate a zero-order process. The consequent matching of the rates of new bone formation and polymer degradation resulted in more extensive healing at later time points in all regions of the graft. These observations underscore the importance of balancing the rates of new bone formation and degradation to promote healing of settable weight-bearing bone grafts that maintain bone-like strength, while actively remodeling.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アセトニトリル, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
トリフルオロ酢酸, ReagentPlus®, 99%
Sigma-Aldrich
トリフルオロ酢酸, suitable for HPLC, ≥99.0%
Sigma-Aldrich
水酸化カリウム, ACS reagent, ≥85%, pellets
Sigma-Aldrich
トリフルオロ酢酸, puriss. p.a., suitable for HPLC, ≥99.0% (GC)
Sigma-Aldrich
水酸化カリウム, reagent grade, 90%, flakes
Sigma-Aldrich
アセトニトリル, ACS reagent, ≥99.5%
Sigma-Aldrich
アセトニトリル, ≥99.9% (GC)
Sigma-Aldrich
アセトニトリル, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
水酸化カリウム 溶液, 45 wt. % in H2O
Sigma-Aldrich
水酸化カリウム, semiconductor grade, pellets, 99.99% trace metals basis (Purity excludes sodium content.)
Supelco
水酸化カリウム 溶液, volumetric, 8.0 M KOH (8.0N)
Sigma-Aldrich
トリフルオロ酢酸, ≥99%, for protein sequencing
Sigma-Aldrich
水酸化カリウム, ≥85% KOH basis, pellets, white
Sigma-Aldrich
アセトニトリル, suitable for HPLC-GC, ≥99.8% (GC)
Sigma-Aldrich
水酸化カリウム, BioXtra, ≥85% KOH basis
Sigma-Aldrich
水酸化カリウム, technical, ≥85%, powder
Sigma-Aldrich
水酸化カリウム, puriss., meets analytical specification of Ph. Eur., BP, 85-100.5%, pellets
Sigma-Aldrich
アセトニトリル, biotech. grade, ≥99.93%
Sigma-Aldrich
水酸化カリウム, pellets, reag. Ph. Eur., ≥85%
Sigma-Aldrich
DABCO® 33-LV
Sigma-Aldrich
水酸化カリウム, anhydrous, ≥99.95% trace metals basis
Sigma-Aldrich
アセトニトリル, anhydrous, 99.8%
USP
D-(+)-トレハロース 二水和物, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
水酸化カリウム, puriss. p.a., ≥86% (T), pellets
Sigma-Aldrich
アセトニトリル, ReagentPlus®, 99%
Sigma-Aldrich
アセトニトリル, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
1,4-ジアザビシクロ[2.2.2]オクタン, ReagentPlus®, ≥99%
Sigma-Aldrich
アセトニトリル, suitable for DNA synthesis, ≥99.9% (GC)
Sigma-Aldrich
アセトニトリル, ≥99.8%, suitable for HPLC